Aspirin use reduces risk of death in hospitalised Covid patients by 47%, new study finds.
HOSPITALISED coronavirus patients who were taking aspirin daily had a lower risk of ICU admission, ventilation, and dying from SARS-CoV-2 virus, according to a new study led by researchers at the University of Maryland School of Medicine (UMSOM).
Researchers studied 412 patients hospitalised with Covid-19.
They found that aspirin use was associated with a 44 per cent reduction in the risk of being put on a mechanical ventilator and a 43 per cent decrease in the risk of ICU admissions.
But more significantly, they discovered a 47 per cent decrease in the risk of dying in the hospital compared to those who were not taking aspirin.
And the patients in the aspirin group did not experience a significant increase in adverse events such as major bleeding while hospitalised.
Associate Professor of Anesthesiology at UMSOM, Michael A. Mazzeffi, MD, said: “We believe that the blood-thinning effects of aspirin provide benefits for Covid-19 patients by preventing microclot formation.”
He added that patients diagnosed with Covid-19 may want to consider taking a daily aspirin but warned they must check with their doctor first.
Confirmatory studies are still required to prove that aspirin use leads to better outcomes for Covid-19 patients.
Thank you for taking the time to read this news article “Aspirin use reduces risk of death in hospitalised Covid patients by 47%”. For more UK daily news, Spanish daily news and Global news stories, visit the Euro Weekly News home page.
Euro Weekly News is delighted to continue be able to bring you a range of News from around Spain in English and Global News live as it happens.
Euro Weekly News doesn’t cost you anything but your internet connection. Whether it’s bringing you the local Spanish news or the International news today, we’ve got you covered!
Euro Weekly News, the leading free local and national newspaper in Spain, the people’s paper, we lead others follow!